Cellular Therapy and Hematologic Malignancies

Grand Rounds

Speaker:         Members of the ID Team, including

Meredith Clement, MD , Fellow, Division of Infectious Diseases 

Barbara D. Alexander, MD, MHS, Director, Transplant Infectious Diseases Service,

Head, Clinical Mycology Laboratory, Director, Med Microbiology & Transplant ID Fellowship Programs,     Professor of Medicine and Pathology

Jennifer Saullo, MD, PharmD, Transplant Infectious Diseases Service

Topics:            Reverse Algorithm Syphilis Testing at Duke – What you need to know for the change.

Date:               Tuesday, March 7, 2017

ime:                 8:00 a.m. – 9:00 a.m.

Location:         Conference Room 9015 North Pavilion

Summary of Faculty Disclosure/Planning Committee:

The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CE activity:  Jennifer Saullo, MD, Pharm.D.

The following speakers and/or planning committee members have indicated they have the following relationship(s) with industry to disclose relative to the content of this CE activity:  Dr. Meredith Clement, MD has royalties with UptoDate.  Dr. Barbara Alexander has indicated that she is a principal investigator and consultant for Astellas; principal investigator for Viamet; principal investigator and consultant for Scynexis; consultant for Cidara and principal investigator for Shire.  Dr. Mitchell Horwitz has indicated that he is an Advisory Board Member for Genzyme and is the Principal Investigator for both Otsuka and Pfizer.

Joint Accreditation Statement

In support of improving patient care, Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.

Education Credits

Category 1*: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

It is the policy of the Duke University Health System Clinical Education and Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.

You must text the six letter code provided by the speaker to (919)213-8033 to receive credit for attending this conference.